Dilan Patel, MD

Bone Marrow Transplant Specialist, Medical Oncologist

Dilan Patel

Appointment Options

Whether you’re seeking a new patient appointment or exploring treatment options and looking for a second opinion, our Siteman care coordinators are ready to assist you.

Expertise & Training

Video thumbnail for Dilan Patel, MD

Watch video on YouTube

Dilan Patel, MD

6 mins

Dilan Patel, MD, medicine oncologist from Siteman Cancer Center, discusses why he became a physician and his approach to patient care. Inspired by his father, also a physician, Dr. Patel was drawn to medicine through powerful dinner table stores of healing and human connection. At Siteman, he meets patients where they are, with honest, empathy, and a deep commitment to supporting their unique journeys. Every interaction starts with a blank slate, recognizing that each patient holds a story worth understanding and honoring with the best possible care.

Clinical Expertise

  • Lymphoma

Primary Academic Title

Assistant Professor, Department of Medicine, Division of Oncology, WashU Medicine

Board Certification

  • 2017: American Board of Internal Medicine
  • 2020: American Board of Internal Medicine, Hematology Board Certification
  • 2020: American Board of Internal Medicine, Medical Oncology Certification

Training

  • 2014 - 2017: Internal Medicine Residency Program, WashU Medicine, St. Louis, MO
  • 2017 - 2020: Hematology/Oncology Fellowship Program, Vanderbilt University Medical Center, Vanderbilt-Ingram Cancer Center, Nashville, TN
  • 2020 - 2021: Advanced BMT Fellow, WashU Medicine, St. Louis, MO

Education

  • 2010: BA, Vanderbilt University, College of Arts & Sciences, Nashville, TN
  • 2014: MD, University of Tennessee Health Science Center, College of Medicine, Memphis TN

Research & Selected Publications

Research Interest

Diffuse large b cell lymphoma (DLBCL), follicular lymphoma, mantle cell lymphoma (MCL) and chronic leukemias.

Research Publications

Converging approaches in the frontline treatment of mantle cell lymphoma
Authors:

Patel DA, Kahl BS

Journal & Year:

Clin Adv Hematol Oncol | 2025

Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium
Authors:

Jain MD, Spiegel JY, Nastoupil LJ, one or more additional authors omitted Patel D, one or more additional authors omitted Dahiya S

Journal & Year:

J Clin Oncol | 2024

SOHO State of the Art Updates and Next Questions: Tailoring Upfront Therapy in Mantle Cell Lymphoma
Authors:

Patel D, Kahl B

Journal & Year:

Clin Lymphoma Myeloma Leuk | 2023